Search

Author/Creator Menzaghi, B.

1. Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients. (February 2019)

Authors:
Gambato, M.; Spinetti, A.; Pasulo, L.; D'ambrosio, R.; Puoti, M.; Schiavini, M.; Fabris, P.; Sacchi, P.; Gulminetti, R.; Carolo, G.; Scotton, P.; Franceschet, I.; Vinci, M.; Viganò, M.; Lobello, S.; Zuin, M.G.; Aghemo, A.; Rumi, M.; Carrara, M.; Manfrin, V.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

Authors:
Di Maio, V. C.; Cento, V.; Di Paolo, D.; Aragri, M.; De Leonardis, F.; Tontodonati, M.; Micheli, V.; Bellocchi, M. C.; Antonucci, F. P.; Bertoli, A.; Lenci, I.; Milana, M.; Gianserra, L.; Melis, M.; Di Biagio, A.; Sarrecchia, C.; Sarmati, L.; Landonio, S.; Francioso, S.; Lambiase, L.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 3(2016:Mar.)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life. Issue 1 (16th February 2017)

Authors:
Cento, V.; Barbaliscia, S.; Lenci, I.; Ruggiero, T.; Masetti, C.; Magni, C.F.; Micheli, V.; Paolucci, S.; Troshina, Y.; Biliotti, E.; Milana, M.; Melis, M.; Teti, E.; Lambiase, L.; Menzaghi, B.; Nicolini, L.A.; Marenco, S.; Di Maio, V.C.; Aragri, M.; Pecchioli, A.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern Italy. (February 2020)

Authors:
Fabris, P.; Noventa, F.; Pasulo, L.; Farina, F.; Carollo, G.; Carlotto, A.; Rovere, P.; Cavinato, S.; Romano, A.; Vario, A.; Fraceschet, I.; Panese, S.; Bertin, T.; Zappalà, F.; Alberti, A.; Lobello, S.; Aghemo, A.; Bruno, R.; Puoti, M.; Rizzardini, G.
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 1
Page Start:
e19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Natural HCV resistance is common in Italy and differently associated to genotypes. Issue 1 (16th February 2017)

Authors:
Sorbo, M.C.; Cento, V.; Bertoli, A.; Lenci, I.; Polilli, E.; Masetti, C.; Gianserra, L.; Teti, E.; Biliotti, E.; Magni, C.F.; Aragri, M.; Micheli, V.; Melis, M.; Nicolini, L.A.; Marenco, S.; Calvaruso, V.; Paolucci, S.; Baldanti, F.; Morisco, F.; Siciliano, M.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy. (February 2019)

Authors:
Pasulo, L.; Gambato, M.; Spinetti, A.; D'Ambrosio, R.; Puoti, M.; Ciancio, A.; Di Marco, V.; Calvaruso, V.; Colombatto, P.; Brunetto, M.; Schiavini, M.; Fabris, P.; Sacchi, P.; Gulminetti, R.; Carolo, G.; Scotton, P.; Pozzan, C.; Vinci, M.; Viganò, M.; Lombardi, A.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗